HOME >> BIOLOGY >> NEWS
Progress toward a targeted therapy for a specific form of leukemia

Leuven, Belgium -- Leukemia, or cancer of the bone marrow, strikes some 700 Belgians each year. Scientists are still searching for the cause of many forms of leukemia, including T-cell acute lymphoblastic leukemia, or T-ALL. Now, VIB researchers connected to the Katholieke Universiteit Leuven have identified a new player in the development of some 10% of the T-ALL cases: MYB. The scientists have discovered that patients in this group have a duplication of the MYB gene, which increases MYB concentrations. Further research has indicated that MYB might well be an important target for therapies for this group of T-ALL patients.

T-cell acute lymphoblastic leukemia (T-ALL)

Our bodies white blood cells combat foreign intruders such as viruses and bacteria. However, in leukemia, the formation of white blood cells is disrupted. The cells in the bone marrow that should develop into white blood cells multiply out of control without fully maturing. These blood cells do not function properly and thus jeopardize the production of normal blood cells. Among other consequences, this makes patients more susceptible to infections. T-ALL is a certain form of leukemia in which immature T-cells (a specific type of blood cells) build up very rapidly. T-ALL is the most prevalent form of cancer in children under 14 years of age, striking children between the ages of 2 and 3 in particular. Today, with optimal treatment using chemotherapy, more than half of the children are cured.

Combined action of several players

The search for the mechanisms that cause T-ALL goes on ceaselessly. Discovering these mechanisms will enable the development of targeted therapies, which are preferred over chemotherapy. Scientists know that T-ALL arises only when defects occur in several genes simultaneously. So it is not only important to identify the genes that underlie T-ALL, but also to discover which combinations trigger the disease. This is an important step in
'"/>

Contact: Ann Van Gysel
info@vib.be
329-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
15-Apr-2007


Page: 1 2 3

Related biology news :

1. Breast cancer milieu -- Progression, tamoxifen sensitivity, and DNA reversion
2. Progress against sarcoma
3. Progress toward artificial photosynthesis?
4. 2nd annual Albert Szent-Gyrgyi Prize for Progress in Cancer Research awarded to Webster K. Cavenee
5. Progress in battle against life-threatening acute allergy
6. Progress report on Homogeneous Assay project
7. Progress being made in exploring potential use of stem cells to treat heart disease
8. Media Invite: Dinner to award prize for Progress in Cancer Research
9. Progress needed on global regime for access to genetic resources and benefit-sharing
10. Albert Szent-Gyrgyi Prize for Progress in Cancer Research announced
11. Progress toward a new remedy for chronic urinary tract infections?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... ... September 12, 2018 , ... JoVE, the leading producer and ... the professional development of academic librarians by sponsoring four award-winners to attend the ... to submit successful strategies to increase collaboration among librarians and STEM faculty and ...
(Date:9/7/2018)... COLLEGE STATION, Texas (PRWEB) , ... September 05, ... ... iCON Turnkey Facility Platform for a mAb manufacturing facility late last year, IPS-Integrated ... ÜBERcellFLEX PODs for the manufacturing of autologous cell therapies. The iCON solution provides ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... ... Amedica Corporation (NASDAQ: AMDA) to purchase its commercial spine business, which includes its ... directly related to the spine that result from it. The deal will make ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... , ... August 28, 2018 , ... ... retailer of contact lenses, has been ranked in 1138th place on the 27th ... companies. , The list represents the most successful companies within the American ...
(Date:8/26/2018)... ... August 23, 2018 , ... LabRoots , the ... around the world, will host the 4th Annual Microbiology and Immunology Virtual Event ... disciplines, encompassing various research areas including medicine, agriculture, and space. , During ...
(Date:8/21/2018)... ... August 21, 2018 , ... ... medical device compliance and commercialization, has just released a new paper discussing ... presented by Dr. Mario Kossmann, ESEP at the 28th Annual INCOSE International ...
(Date:8/17/2018)... ... August 16, 2018 , ... ... results from the AmbryShare project were published today in JAMA Oncology, identifying new ... exome study ever conducted. , Every year hereditary breast cancer affects more than ...
Breaking Biology Technology:
Cached News: